Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
[Routine Practice Data for Evaluating Intervention Effects: Part 2 of the Manual].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))

Hoffmann F, Kaiser T, Apfelbacher C, Benz S, Bierbaum T, Dreinhöfer K, Hauptmann M, Heidecke CD, Koller M, Kostuj T, Ortmann O, Schmitt J, Schünemann H, Veit C, Hoffmann W, Klinkhammer-Schalke M.
PMID: 34077984
Gesundheitswesen. 2021 Jun;83(6):e40. doi: 10.1055/a-1516-8823. Epub 2021 Jun 02.

No abstract available.

Cite
Hoffmann F, Kaiser T, Apfelbacher C, et al. Versorgungsnahe Daten zur Evaluation von Interventionseffekten: Teil 2 des Manuals. [Routine Practice Data for Evaluating Intervention Effects: Part 2 of the Manual]. Gesundheitswesen. 2021;83(6):e40doi: 10.1055/a-1516-8823.
Hoffmann, F., Kaiser, T., Apfelbacher, C., Benz, S., Bierbaum, T., Dreinhöfer, K., Hauptmann, M., Heidecke, C. D., Koller, M., Kostuj, T., Ortmann, O., Schmitt, J., Schünemann, H., Veit, C., Hoffmann, W., & Klinkhammer-Schalke, M. (2021). Versorgungsnahe Daten zur Evaluation von Interventionseffekten: Teil 2 des Manuals. [Routine Practice Data for Evaluating Intervention Effects: Part 2 of the Manual]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 83(6), e40. https://doi.org/10.1055/a-1516-8823
Hoffmann, Falk, et al. "Versorgungsnahe Daten zur Evaluation von Interventionseffekten: Teil 2 des Manuals." [Routine Practice Data for Evaluating Intervention Effects: Part 2 of the Manual]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) vol. 83,6 (2021): e40. doi: https://doi.org/10.1055/a-1516-8823
Hoffmann F, Kaiser T, Apfelbacher C, Benz S, Bierbaum T, Dreinhöfer K, Hauptmann M, Heidecke CD, Koller M, Kostuj T, Ortmann O, Schmitt J, Schünemann H, Veit C, Hoffmann W, Klinkhammer-Schalke M. Versorgungsnahe Daten zur Evaluation von Interventionseffekten: Teil 2 des Manuals. [Routine Practice Data for Evaluating Intervention Effects: Part 2 of the Manual]. Gesundheitswesen. 2021 Jun;83(6):e40. doi: 10.1055/a-1516-8823. Epub 2021 Jun 02. German. PMID: 34077984.
Copy Download .nbib Format: NLM
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

BMC blood disorders

Fuchs M, Reinhöfer M, Ragoschke-Schumm A, Sayer HG, Böer K, Witte OW, Hochhaus A, Axer H.
PMID: 22871019
BMC Blood Disord. 2012 Aug 07;12:9. doi: 10.1186/1471-2326-12-9.

BACKGROUND: This case report highlights the relevance of quantifying the BCR-ABL gene in cerebrospinal fluid of patients with suspected relapse of chronic myeloid leukemia in the central nervous system.CASE PRESENTATION: We report on a female patient with isolated central...

Cite
Fuchs M, Reinhöfer M, Ragoschke-Schumm A, et al. Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation. BMC Blood Disord. 2012;12:9doi: 10.1186/1471-2326-12-9.
Fuchs, M., Reinhöfer, M., Ragoschke-Schumm, A., Sayer, H. G., Böer, K., Witte, O. W., Hochhaus, A., & Axer, H. (2012). Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation. BMC blood disorders, 129. https://doi.org/10.1186/1471-2326-12-9
Fuchs, Mary, et al. "Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation." BMC blood disorders vol. 12 (2012): 9. doi: https://doi.org/10.1186/1471-2326-12-9
Fuchs M, Reinhöfer M, Ragoschke-Schumm A, Sayer HG, Böer K, Witte OW, Hochhaus A, Axer H. Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation. BMC Blood Disord. 2012 Aug 07;12:9. doi: 10.1186/1471-2326-12-9. PMID: 22871019; PMCID: PMC3469402.
Copy Download .nbib Format: NLM
RENaBack: low back pain patients in rehabilitation-study protocol for a multicenter, randomized controlled trial.

Trials

Puerto Valencia L, Arampatzis D, Beck H, Dreinhöfer K, Drießlein D, Mau W, Zimmer JM, Schäfer M, Steinfeldt F, Wippert PM.
PMID: 34922613
Trials. 2021 Dec 18;22(1):932. doi: 10.1186/s13063-021-05823-3.

BACKGROUND: Millions of people in Germany suffer from chronic pain, in which course and intensity are multifactorial. Besides physical injuries, certain psychosocial risk factors are involved in the disease process. The national health care guidelines for the diagnosis and...

Cite
Puerto Valencia L, Arampatzis D, Beck H, et al. RENaBack: low back pain patients in rehabilitation-study protocol for a multicenter, randomized controlled trial. Trials. 2021;22(1):932doi: 10.1186/s13063-021-05823-3.
Puerto Valencia, L., Arampatzis, D., Beck, H., Dreinhöfer, K., Drießlein, D., Mau, W., Zimmer, J. M., Schäfer, M., Steinfeldt, F., & Wippert, P. M. (2021). RENaBack: low back pain patients in rehabilitation-study protocol for a multicenter, randomized controlled trial. Trials, 22(1), 932. https://doi.org/10.1186/s13063-021-05823-3
Puerto Valencia, Laura, et al. "RENaBack: low back pain patients in rehabilitation-study protocol for a multicenter, randomized controlled trial." Trials vol. 22,1 (2021): 932. doi: https://doi.org/10.1186/s13063-021-05823-3
Puerto Valencia L, Arampatzis D, Beck H, Dreinhöfer K, Drießlein D, Mau W, Zimmer JM, Schäfer M, Steinfeldt F, Wippert PM. RENaBack: low back pain patients in rehabilitation-study protocol for a multicenter, randomized controlled trial. Trials. 2021 Dec 18;22(1):932. doi: 10.1186/s13063-021-05823-3. PMID: 34922613.
Copy Download .nbib Format: NLM
[Not Available].

Der Orthopade

Dreinhöfer K.
PMID: 22581153
Orthopade. 2012 May;41(5):413. doi: 10.1007/s00132-011-1885-4.

No abstract available.

Cite
Dreinhöfer K. Osteoporose, Knochenerkrankungen. Ösophaguskarzinome--Zusammenhang mit langfristiger Einnahme? [Not Available]. Orthopade. 2012;41(5):413doi: 10.1007/s00132-011-1885-4.
Dreinhöfer, K. (2012). Osteoporose, Knochenerkrankungen. Ösophaguskarzinome--Zusammenhang mit langfristiger Einnahme? [Not Available]. Der Orthopade, 41(5), 413. https://doi.org/10.1007/s00132-011-1885-4
Dreinhöfer, K. "Osteoporose, Knochenerkrankungen. Ösophaguskarzinome--Zusammenhang mit langfristiger Einnahme?" [Not Available]. Der Orthopade vol. 41,5 (2012): 413. doi: https://doi.org/10.1007/s00132-011-1885-4
Dreinhöfer K. Osteoporose, Knochenerkrankungen. Ösophaguskarzinome--Zusammenhang mit langfristiger Einnahme? [Not Available]. Orthopade. 2012 May;41(5):413. doi: 10.1007/s00132-011-1885-4. German. PMID: 22581153.
Copy Download .nbib Format: NLM
Fragility fractures - Global call to action.

Best practice & research. Clinical rheumatology

Dreinhöfer KE.
PMID: 31547978
Best Pract Res Clin Rheumatol. 2019 Apr;33(2):203-204. doi: 10.1016/j.berh.2019.101430. Epub 2019 Aug 08.

No abstract available.

Cite
Dreinhöfer KE. Fragility fractures - Global call to action. Best Pract Res Clin Rheumatol. 2019;33(2):203-204doi: 10.1016/j.berh.2019.101430.
Dreinhöfer, K. E. (2019). Fragility fractures - Global call to action. Best practice & research. Clinical rheumatology, 33(2), 203-204. https://doi.org/10.1016/j.berh.2019.101430
Dreinhöfer, Karsten E. "Fragility fractures - Global call to action." Best practice & research. Clinical rheumatology vol. 33,2 (2019): 203-204. doi: https://doi.org/10.1016/j.berh.2019.101430
Dreinhöfer KE. Fragility fractures - Global call to action. Best Pract Res Clin Rheumatol. 2019 Apr;33(2):203-204. doi: 10.1016/j.berh.2019.101430. Epub 2019 Aug 08. PMID: 31547978.
Copy Download .nbib Format: NLM
Symptoms, antibody levels and vaccination attitude after asymptomatic to moderate COVID-19 infection in 200 healthcare workers.

GMS hygiene and infection control

Harsch IA, Ortloff A, Reinhöfer M, Epstude J.
PMID: 34123703
GMS Hyg Infect Control. 2021 Apr 19;16:Doc15. doi: 10.3205/dgkh000386. eCollection 2021.

No abstract available.

Cite
Harsch IA, Ortloff A, Reinhöfer M, et al. Symptoms, antibody levels and vaccination attitude after asymptomatic to moderate COVID-19 infection in 200 healthcare workers. GMS Hyg Infect Control. 2021;16:Doc15doi: 10.3205/dgkh000386.
Harsch, I. A., Ortloff, A., Reinhöfer, M., & Epstude, J. (2021). Symptoms, antibody levels and vaccination attitude after asymptomatic to moderate COVID-19 infection in 200 healthcare workers. GMS hygiene and infection control, 16Doc15. https://doi.org/10.3205/dgkh000386
Harsch, Igor Alexander, et al. "Symptoms, antibody levels and vaccination attitude after asymptomatic to moderate COVID-19 infection in 200 healthcare workers." GMS hygiene and infection control vol. 16 (2021): Doc15. doi: https://doi.org/10.3205/dgkh000386
Harsch IA, Ortloff A, Reinhöfer M, Epstude J. Symptoms, antibody levels and vaccination attitude after asymptomatic to moderate COVID-19 infection in 200 healthcare workers. GMS Hyg Infect Control. 2021 Apr 19;16:Doc15. doi: 10.3205/dgkh000386. eCollection 2021. PMID: 34123703; PMCID: PMC8165487.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries